Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

More articles from Plenary Session Abstract

  • You have access
    Novel Effects of Inflammatory Cell Proteases on Vascular Endothelia
    GA Preston, WF Pendergraft, JJ Yang, JC Jennette and RJ Falk
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-50;
  • You have access
    Campath 1-H (Anti-CD52) for Refractory Vasculitis: Retrospective Cambridge Experience 1989–1999
    DRW Jayne
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-129;
  • You have access
    HMG-CoA Reductase Inhibitors Decrease Anca-Mediated Activation Of Human Neutrophils
    M Choi, S Rolle, M Rane, H Haller, FC Luft and R Kettritz
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-68;
  • You have access
    Sequential Epitope Mapping of the Myeloperoxidase Antigen
    DM Wynn and JA James
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-60;
  • You have access
    Henoch-Schönlein Purpura and Cutaneous Leukocy-Toclastic Angiitis Exhibit Different HLA-DRB1 Associations
    MM Amoli, W Thomson, AH Hajeer, MC Calviño, C Garcia-Porrua, WER Ollier and MA Gonzalez-Gay
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-90;
  • You have access
    Randomized Trial of Cyclophosphamide Versus Methotrexate for Induction of Remission in “Non-Renal” Anca-Associated Vasculitis
    K de Groot, N Rasmussen, JW Cohen Tervaert, DRW Jayne and
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-116;
  • You have access
    Ethnic Disparity in the Incidence of Temporal Arteri-Tis: a 32-Year Experience at an Urban Medical Center
    MJ Regan, WR Green and JH Stone
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-83;

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire